Therapixel announces close of 15 M€ series B financing to deploy MammoScreen® 2D/3D

The Company will accelerate the commercial deployment of…


Therapixel-presents-MammoScreen-ECR 2021

Therapixel will be showcasing MammoScreen™ at the virtual ECR 2021

Stop by our booth to learn more about our FDA-cleared and…


Partnersgip

Therapixel and RAD-AID International Announce Breast Imaging AI Collaboration for Global Health

The collaboration donates and supports AI for making breast…


Therapixel participates at the JFR 2020

Therapixel participates in the Journées Francophones de Radiologie 2020

Experience the Award-winning MammoScreen™ at our virtual…


Therapixel is certified ISO 27001

Therapixel is now ISO/IEC 27001 certified

Our information security management system is compliant…


MammoScreen received 510(k) clearance

Therapixel receives FDA 510(k) clearance for MammoScreen™

AI-powered reading aid for screening mammography improves…